Health ❯ Healthcare ❯ Patient Safety

Adverse Effects

Liver Injury Treatment-Related Adverse Effects Medication Interactions Reporting Mechanisms Pancreatitis Treatment-Emergent Adverse Effects Clinical Outcomes Drug Side Effects Major Bleeding Meningioma Risk

Lilly’s Oral Drug Foundayo Matches Insulin on Heart Safety in Major Diabetes Trial

The finding sets up a near-term FDA filing under a priority review voucher.

EU Drug Panel Backs Imdylltra for Relapsed Small Cell Lung Cancer

Anvisa Issues Safety Alert on Misuse of Dermal Fillers in Brazil

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

Peru Updates Paracetamol Labels Over Rare Acidosis Risk, Issues Clinical Guidance

JAMA Study Finds 1 in 4 Medicare Patients With Dementia Receive Risky CNS-Active Drugs

Prescrire Adds Four Medicines to Its 2026 ‘To Avoid’ List in France

Denmark Awards Payouts to Four Patients Over Vision Loss Linked to Ozempic and Wegovy

FDA Adds Boxed Warning to Elevidys, Narrows Use to Ambulatory Patients 4 and Older

FDA Issues Warning Letters to 18 Websites Selling Unapproved Botox-Like Injectables

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

Phase 3 Trial Shows Baxdrostat Lowers Blood Pressure by About 10 mmHg in Hard-to-Control Hypertension

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

Pharmacogenetic Screening Halves Severe Chemotherapy Reactions in Gastrointestinal Cancer Patients

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market

MHRA Warns of Small Guillain-Barré Syndrome Risk With RSV Vaccines

BMJ Reveals Data Flaws in Pivotal Ticagrelor FDA Approval Studies

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

SYNT-101 Shows Promise in Early Human Trials as a Non-Invasive Obesity Treatment